Cargando…
Oxidative and Endoplasmic Reticulum Stress Represent Novel Therapeutic Targets for Choroideremia
Choroideremia (CHM) is a rare X-linked chorioretinal dystrophy, affecting the photoreceptors, retinal pigment epithelium (RPE) and choroid, with no approved therapy. CHM is caused by mutations in the CHM gene, which encodes the ubiquitously expressed Rab escort protein 1 (REP1). REP1 is involved in...
Autores principales: | Sarkar, Hajrah, Lahne, Manuela, Nair, Neelima, Moosajee, Mariya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10525549/ https://www.ncbi.nlm.nih.gov/pubmed/37759997 http://dx.doi.org/10.3390/antiox12091694 |
Ejemplares similares
-
Involvement of Oxidative and Endoplasmic Reticulum Stress in RDH12-Related Retinopathies
por: Sarkar, Hajrah, et al.
Publicado: (2021) -
Nonsense-mediated mRNA decay efficiency varies in choroideremia providing a target to boost small molecule therapeutics
por: Sarkar, Hajrah, et al.
Publicado: (2019) -
Choroideremia: from genetic and clinical phenotyping to gene therapy and future treatments
por: Mitsios, Andreas, et al.
Publicado: (2018) -
REP1 deficiency causes systemic dysfunction of lipid metabolism and oxidative stress in choroideremia
por: Cunha, Dulce Lima, et al.
Publicado: (2021) -
Update on Gene Therapy Clinical Trials for Choroideremia and Potential Experimental Therapies
por: Abbouda, Alessandro, et al.
Publicado: (2021)